The above article [Alsiraj Y, Thatcher SE, Liang CL, Ali H, Ensor M, and Cassis LA (2021) J Pharmacol Exp Ther, 377:326–335, DOI: https://doi.org/10.1124/jpet.121.000525] was accidentally published with the first author’s last name incorrectly listed as AlSiraj. The correct byline for the article is Yasir Alsiraj, Sean E. Thatcher, Ching Ling Liang, Heba Ali, Mark Ensor, and Lisa A. Cassis.
The PDF and HTML versions of the article have been corrected.
The compositor apologizes for any inconvenience caused by these errors.
Footnotes
- Received August 11, 2021.
- Accepted August 11, 2021.
- Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics
In this issue
Correction to “Therapeutic Assessment of Combination Therapy with a Neprilysin Inhibitor and Angiotensin Type 1 Receptor Antagonist on Angiotensin II – Induced Atherosclerosis, Abdominal Aortic Aneurysms, and Hypertensin”
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement